Beta-adrenoceptor-blocking agents: pharmacokinetic differences and their clinical implications illustrated on pindolol.
作者信息
Meier J
出版信息
Cardiology. 1979;64 Suppl 1:1-13.
PMID:42483
Abstract
摘要
相似文献
1
Beta-adrenoceptor-blocking agents: pharmacokinetic differences and their clinical implications illustrated on pindolol.
Cardiology. 1979;64 Suppl 1:1-13.
2
Pharmacokinetics of a new beta-adrenoceptor blocking agent, LF 17-895, in man.
Arzneimittelforschung. 1975 Jul;25(7):1067-72.
3
Pharmacokinetic comparison of pindolol with other beta-adrenoceptor-blocking agents.
Am Heart J. 1982 Aug;104(2 Pt 2):364-73. doi: 10.1016/0002-8703(82)90127-2.
4
Pindolol: a pharmacokinetic comparison with other beta-adrenoceptor blocking agents.
Acta Med Scand Suppl. 1977;606:65-70. doi: 10.1111/j.0954-6820.1977.tb18031.x.
5
Pharmacokinetics and pharmacodynamics of mepindolol sulphate.
Int J Clin Pharmacol Ther Toxicol. 1980 Apr;18(4):169-76.
6
[Hepatic clearance of drugs in kidney failure].
Nephrologie. 1983;4(2):45-7.
7
8
[Beta receptor blockaders. Pharmacokinetics and therapeutic effects].
Internist (Berl). 1982 Nov;23(11):616-23.
9
The pharmacokinetic properties of beta adrenoceptor blocking drugs.
Arch Int Pharmacodyn Ther. 1980;Suppl:27-31.
10
[Pharmacology and clinical pharmacokinetics of nadolol].
Pol Tyg Lek. 1981 Sep 28;36(39):1521-4.
引用本文的文献
1
A pharmacodynamic and pharmacokinetic comparison of pindolol 20 mg retard and a conventional tablet.
Eur J Clin Pharmacol. 1981;20(3):179-83. doi: 10.1007/BF00544595.
2
Metabolism of pindolol in patients with renal failure.
Eur J Clin Pharmacol. 1982;22(5):423-8. doi: 10.1007/BF00542547.
3
Elimination of pindolol in liver disease.
Eur J Clin Pharmacol. 1982;22(3):247-51. doi: 10.1007/BF00545223.
4
Pharmacokinetics of pindolol in Kenyan Africans.
Eur J Clin Pharmacol. 1983;25(3):425-6. doi: 10.1007/BF01037959.
5
Unsuitability of urethane anesthetized rats for testing potential beta-adrenoreceptor blockers.
Experientia. 1982 Apr 15;38(4):517-9. doi: 10.1007/BF01952672.
6
Atenolol overdosage in a patient with progressive renal failure.
West J Med. 1986 Jul;145(1):101-3.
7
Pharmacokinetics of bisoprolol during repeated oral administration to healthy volunteers and patients with kidney or liver disease.
Clin Pharmacokinet. 1987 Aug;13(2):110-7. doi: 10.2165/00003088-198713020-00003.
Zotero 插件